Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Immuron Limited ( (AU:IMC) ) has provided an update.
Immuron Limited has announced a proposed issue of 473,880 ordinary fully paid securities, with the issue date set for July 17, 2025. This move is part of a placement or other type of issue, indicating a strategic effort to raise capital, which could impact the company’s financial standing and market positioning.
More about Immuron Limited
Immuron Limited operates in the biotechnology industry, focusing on the development and commercialization of oral immunotherapeutic products for the treatment of gut-mediated diseases.
Average Trading Volume: 78,544
Technical Sentiment Signal: Sell
Current Market Cap: A$14.97M
For detailed information about IMC stock, go to TipRanks’ Stock Analysis page.